Pricing

Vor Biopharma

2 followers

‌

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Robert Ang

Chief Executive Officer

Robert Ang

Collapse

John King

Chief Commercial Officer

Tania Philipp

VP and Head of People

Eyal Attar

Chief Medical Officer

Gary G.

VP, Head of Quantitative Biology

Sarah Spencer

Vice President, Corporate Communications & Investor Relations

Deborah Lloyd

Vice President Clinical Operations

David Phillips

Senior Vice President, Head of Quality

Brian Bellesheim

Director of Business Development

Kerry Chios

Sr. Director, Head Of Laboratory Operations

Kevin McEvoy

Vice President Information Technology

John Lydeard

Vice President, Head of Discovery & Molecular Engineering

Janet Gee

Associate Director, Financial Planning and Analysis

Board & advisors

Chairman

Independent Director

Director

Director

Director

Teams

+33

Scientific Research Team

36 members

Engineering and Development Team

10 members

Clinical Operations Team

8 members

Leadership Team

3 members

Regulatory Affairs and Quality Assurance Team

4 members

Finance and Accounting Team

3 members

Offices

Similar companies

SpringWorks Therapeutics

6 followers

REVOLUTION Medicines

5 followers

C4 Therapeutics

5 followers

Summit Therapeutics

5 followers

Inari

3 followers

Dyne Therapeutics

3 followers

Beta Bionics

3 followers

Rigel Pharmaceuticals

3 followers

Precigen

3 followers

PureTech Health

3 followers

Arcturus Therapeutics

2 followers

Explore companies